Systematic study of five lipidated GLP-1 analogs reveals that lipidation position and type significantly affect solubility, structure, and long-term stability.
5 analogsSystematic comparison varying lipidation position and lipid type on GLP-1 physical stability
What the researchers found
Lipidation position and lipid nature significantly influence GLP-1 analog solubility, oligomerization, and long-term physical stability.
Why it matters
Physical stability determines whether a peptide drug can be manufactured, stored, and delivered reliably — this data guides next-generation GLP-1 drug design.
The numbers in context
Five lipidated GLP-1 analogs tested; all showed reduced solubility, increased alpha-helical content, larger oligomeric species vs non-lipidated GLP-1.
How the study worked
Systematic biophysical comparison of five lipidated GLP-1 analogs varying in lipidation site and lipid type.
Who was studied
N/A
What this study cannot tell us
In vitro study — stability in formulated drug products may differ from these buffer conditions.
How to read the evidence
Systematic biophysical study — excellent for pharmaceutical development guidance but no clinical data.
When this study was published
Published in 2025, informing the ongoing development pipeline of next-generation lipidated GLP-1 drugs.
The bigger picture
As the GLP-1 drug market grows, understanding structure-stability relationships accelerates development of improved analogs.
Questions still open
- Which lipidation strategy offers the best combination of stability and efficacy?
- Can stability predictions from this data accelerate drug candidate selection?
Common questions
Why are some GLP-1 drugs weekly and others daily?
How are new GLP-1 drugs designed?
Read the original research
Effect of Lipidation on the Structure, Oligomerization, and Aggregation of Glucagon-like Peptide 1.
Bioconjugate chemistry, 36(3), 401-414
Citation
Přáda Brichtová, Eva; Edu, Irina A; Li, Xinyang; Becher, Frederik; Gomes Dos Santos, Ana L; Jackson, Sophie E. (2025). Effect of Lipidation on the Structure, Oligomerization, and Aggregation of Glucagon-like Peptide 1.. Bioconjugate chemistry, 36(3), 401-414. https://doi.org/10.1021/acs.bioconjchem.4c00484